About Us
Team
Investment Focus
Laboratory Products
Laboratory Services
Contract Manufacturing
Pharma Services
Specialty Pharma
Working With Us
Portfolio
News
Contact
News
January 5, 2021
January 5, 2021
Genezen Laboratories Receives Growth Equity Investment from Ampersand Capital Partners
December 7, 2020
December 7, 2020
Adaptas Solutions Acquires Cadence Fluidics
December 2, 2020
December 2, 2020
N2 Biomedical Appoints Eric Tobin To Chief Executive Officer
December 1, 2020
December 1, 2020
Ampersand Capital Partners Establishes Portfolio Acceleration Team
November 19, 2020
November 19, 2020
Ampersand Announced Today the $670 Million Closing of the Ampersand Continuation Fund (“AMP-CF”) with Confluent Medical Technologies as Core Asset
November 11, 2020
November 11, 2020
With new CEO on board, Germany’s Vibalogics lays out $150M for Boston viral vector site
October 21, 2020
October 21, 2020
StageBio Expands Its Global Presence With Acquisition of TPL Path Labs
October 2, 2020
October 2, 2020
CEPI establishes global network of laboratories to centralise assessment of COVID-19 vaccine candidates
September 21, 2020
September 21, 2020
GeneWerk GmbH Announces Growth Equity Investment from Ampersand Capital Partners
September 21, 2020
September 21, 2020
Ampersand Capital Partners Acquires American Laboratory Products Company
Prev page
1
2
3
4
...
14
Next page
